RhumbLine Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.4M | Buy |
200,485
+19,022
| +10% | +$6.2M | 0.06% | 276 |
|
|
2025
Q1 | $49M | Buy |
181,463
+1,885
| +1% | +$509K | 0.05% | 342 |
|
|
2024
Q4 | $42.3M | Sell |
179,578
-1,850
| -1% | -$435K | 0.04% | 390 |
|
|
2024
Q3 | $49.9M | Buy |
181,428
+8,101
| +5% | +$2.23M | 0.05% | 340 |
|
|
2024
Q2 | $42.1M | Sell |
173,327
-362
| -0.2% | -$88K | 0.04% | 369 |
|
|
2024
Q1 | $26M | Buy |
173,689
+816
| +0.5% | +$122K | 0.02% | 565 |
|
|
2023
Q4 | $33.1M | Buy |
172,873
+802
| +0.5% | +$154K | 0.03% | 439 |
|
|
2023
Q3 | $30.5M | Sell |
172,071
-3,263
| -2% | -$578K | 0.04% | 440 |
|
|
2023
Q2 | $33.3M | Buy |
175,334
+17,439
| +11% | +$3.31M | 0.04% | 422 |
|
|
2023
Q1 | $31.6M | Buy |
157,895
+9,499
| +6% | +$1.9M | 0.04% | 416 |
|
|
2022
Q4 | $35.3M | Buy |
148,396
+11,711
| +9% | +$2.78M | 0.05% | 363 |
|
|
2022
Q3 | $27.4M | Buy |
136,685
+8,174
| +6% | +$1.64M | 0.04% | 411 |
|
|
2022
Q2 | $18.7M | Buy |
128,511
+12,634
| +11% | +$1.84M | 0.03% | 571 |
|
|
2022
Q1 | $18.9M | Sell |
115,877
-3,955
| -3% | -$646K | 0.02% | 609 |
|
|
2021
Q4 | $20.3M | Buy |
119,832
+3,723
| +3% | +$631K | 0.02% | 613 |
|
|
2021
Q3 | $21.9M | Sell |
116,109
-306
| -0.3% | -$57.8K | 0.03% | 535 |
|
|
2021
Q2 | $19.7M | Sell |
116,415
-5,608
| -5% | -$951K | 0.03% | 606 |
|
|
2021
Q1 | $17.2M | Sell |
122,023
-4,549
| -4% | -$642K | 0.02% | 668 |
|
|
2020
Q4 | $16.5M | Sell |
126,572
-7,326
| -5% | -$952K | 0.02% | 638 |
|
|
2020
Q3 | $19.5M | Sell |
133,898
-6,577
| -5% | -$958K | 0.03% | 480 |
|
|
2020
Q2 | $20.8M | Buy |
140,475
+28,498
| +25% | +$4.22M | 0.03% | 436 |
|
|
2020
Q1 | $12.2M | Buy |
111,977
+5,872
| +6% | +$639K | 0.03% | 574 |
|
|
2019
Q4 | $12.2M | Buy |
106,105
+3,059
| +3% | +$352K | 0.02% | 720 |
|
|
2019
Q3 | $8.29M | Sell |
103,046
-9
| -0% | -$724 | 0.02% | 884 |
|
|
2019
Q2 | $7.48M | Buy |
103,055
+10,164
| +11% | +$738K | 0.01% | 952 |
|
|
2019
Q1 | $8.68M | Buy |
92,891
+2,295
| +3% | +$214K | 0.02% | 838 |
|
|
2018
Q4 | $6.61M | Sell |
90,596
-5,849
| -6% | -$426K | 0.01% | 934 |
|
|
2018
Q3 | $8.44M | Sell |
96,445
-1,501
| -2% | -$131K | 0.02% | 773 |
|
|
2018
Q2 | $9.65M | Buy |
97,946
+2,591
| +3% | +$255K | 0.02% | 701 |
|
|
2018
Q1 | $11.4M | Sell |
95,355
-4,560
| -5% | -$543K | 0.02% | 613 |
|
|
2017
Q4 | $12.7M | Buy |
99,915
+7,347
| +8% | +$933K | 0.03% | 588 |
|
|
2017
Q3 | $10.9M | Buy |
92,568
+1,346
| +1% | +$158K | 0.02% | 623 |
|
|
2017
Q2 | $7.28M | Sell |
91,222
-3,189
| -3% | -$254K | 0.02% | 799 |
|
|
2017
Q1 | $4.84M | Buy |
94,411
+4,028
| +4% | +$206K | 0.01% | 1021 |
|
|
2016
Q4 | $3.38M | Buy |
90,383
+7,712
| +9% | +$289K | 0.01% | 1143 |
|
|
2016
Q3 | $5.6M | Buy |
82,671
+2,407
| +3% | +$163K | 0.02% | 824 |
|
|
2016
Q2 | $4.45M | Buy |
80,264
+4,740
| +6% | +$263K | 0.01% | 872 |
|
|
2016
Q1 | $4.74M | Sell |
75,524
-150
| -0.2% | -$9.42K | 0.01% | 860 |
|
|
2015
Q4 | $7.12M | Buy |
75,674
+2,053
| +3% | +$193K | 0.02% | 652 |
|
|
2015
Q3 | $5.92M | Buy |
73,621
+3,281
| +5% | +$264K | 0.02% | 728 |
|
|
2015
Q2 | $8.43M | Buy |
70,340
+11,510
| +20% | +$1.38M | 0.03% | 590 |
|
|
2015
Q1 | $6.14M | Buy |
58,830
+5,081
| +9% | +$531K | 0.02% | 738 |
|
|
2014
Q4 | $5.21M | Sell |
53,749
-131
| -0.2% | -$12.7K | 0.02% | 775 |
|
|
2014
Q3 | $4.21M | Sell |
53,880
-308
| -0.6% | -$24.1K | 0.01% | 856 |
|
|
2014
Q2 | $3.42M | Sell |
54,188
-8,952
| -14% | -$565K | 0.01% | 1019 |
|
|
2014
Q1 | $4.24M | Sell |
63,140
-2,860
| -4% | -$192K | 0.01% | 909 |
|
|
2013
Q4 | $4.25M | Buy |
66,000
+2,140
| +3% | +$138K | 0.01% | 911 |
|
|
2013
Q3 | $4.09M | Buy |
63,860
+679
| +1% | +$43.5K | 0.01% | 913 |
|
|
2013
Q2 | $1.96M | Buy |
+63,181
| New | +$1.96M | 0.01% | 1314 |
|